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his study investigated the presence of human papillomavirus (HPV) DNA and viral types in 33 cases of oral squamous cells
carcinoma (OSCC) and compared the immunohistochemical expression of the cell-cycle markers p21 and pRb between cases of
the disease with and without HPV. DNA was extracted from paraffin-embedded tissue and amplified by PCR for the detection
of HPV DNA. Viral typing was performed by dot blot hybridization. Immunohistochemistry was performed by the streptavidin-
biotin technique. HPV DNA was detected in 11 (33.33%) of the 33 cases. The prevalent viral type was HPV 18 (81.81%). A
significant association was observed between the presence of HPV and immunohistochemical expression of pRb, but not
between p21 expression and the presence of the virus. The low frequency of detection of HPV DNA in OSCC suggests a
possible participation of the virus in the development and progression of only a subgroup of these tumors.
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INTRODUCTION
Various studies have investigated the role of human
papillomavirus (HPV) in oral squamous cells carcinoma
(OSCC) but the results are highly controversial. Most reports
have shown that HPV 16 is the most prevalent type in both
oral and genital tumors1.
Abnormalities in several components of the cell-cycle
regulatory machinery have been observed in oral cancers
as well as in other types of cancer. Protein p21 is a universal
inhibitor of cyclin-dependent kinases (CDKs) that mediates
cell cycle arrest in the G1 and G2/M phase to prevent DNA
replication in cells in which this molecule is damaged. Protein
pRb plays an important role in cell-cycle regulation. When
cells are stimulated by growth factors, this protein is
inactivated by phosphorylation and cells progress from the
G1 to the S phase. The hyperphosphorylated form of pRb
releases E2F transcription factors which, in turn, activate
the transcription of various target genes17.
In view of the importance of HPV in carcinogenesis, the
objective of this study was to investigate the presence of
HPV DNA and the most frequent viral types in patients with
OSCC, and to compare the immunohistochemical expression
of the cell-cycle proteins p21 and pRb between HPV-positive
and HPV-negative cases in order to establish a possible
correlation between the expression of these proteins and
HPV infection in OSCC.
MATERIAL AND METHODS
Thirty-three cases of OSCC were retrieved from the 1996-
2004 pathology service archives of the Department of
Dentistry of the Federal University of Rio Grande do Norte
and Hospital Dr. Luis Antônio, both in the city of Natal, RN,
Brazil. Eligible cases were males or females aged 30 years or
older (mean age= 65.45 years; range= 30-93 years) with
newly diagnosed, histologically confirmed OSCC and not
submitted to any kind of therapy (chemotherapy,
radiotherapy or surgery). Topographic locations included
malignancies of the tongue, gingiva, floor of mouth, palate,
buccal mucosa, retromolar area and lip.
The presence of HPV DNA and immunohistochemical
expression of proteins p21 and pRb were studied in
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specimens fixed in formalin and embedded in paraffin. Ten
10-µm histological sections were used for the study of HPV,
two 3-µm sections were stained with hematoxylin and eosin
for histopathological analysis, and two 3-µm sections were
submitted to immunohistochemistry.
DNA was extracted using the ammonium acetate-
isopropanol technique. This method was developed by the
research team of the Laboratory of Molecular Biology of
the Dental School of the University of São Paulo (USP)10
and consisted of the initial removal of paraffin by baths in
xylene heated to 65oC followed by hydration of the tissues
in a decreasing ethanol series (absolute, 95%, 70% and 50%).
Then, 400 µL sterile lysis buffer (50 mM NaCl, 5 mM Tris-
HCl, pH 8, 12.5 mM EDTA, pH 8, and 0.25% SDS) and
proteinase K at a final concentration of 500 µg/mL were
added to the tissue pellet of each sample and the samples
were incubated at 55oC for 3 to 5 days until complete
dissolution of the material. Next, 200 µL of a 4 M ammonium
acetate solution were added to each sample for protein
precipitation, followed by 600 µL 100% isopropanol for DNA
precipitation. Finally, the DNA pellets obtained were washed
with 70% ethanol, dissolved in 50 µL TE buffer and stored
at -20oC.
The samples were submitted to polymerase chain
reaction (PCR) to evaluate the efficacy of DNA extraction.
For this, a pair of primers designated PCO3+
(5’CTTCTGACACAACTGTGTTCACTAGC3’) and PCO4+
(5’TCACCGCAAC TTCATCCACGTTCACC3’) was used
which flank a 110-bp sequence of the human  b-globin gene
present in all human cells12. The reaction was carried out in
an Eppendorf thermocycler (Eppendorf, Netherler, Hamburg,
Germany).
Samples positive for the β-globin gene were analyzed
by PCR regarding the presence of HPV DNA using a pair of
generic primers called GP5+
(5’TTTGTTACTGTGGTAGATACTAC3’) and GP6+
(5’GAAAAATA AACTGTAAATCAT ATTC3')11, which
flank a fragment of about 140 bp of the L1 gene, a highly
conserved sequence in the genome of mucosal (genital and
oral) HPVs. The use of this primer pair permits the detection
and amplification of this DNA segment from at least 23
individual mucosal (genital and oral) HPV types, including
high risk HPV types.
The reaction mixture contained 1.0 µM GP5+/GP6+
(Invitrogen, Life Technologies, Carlsbad, California), 1.0 U
Taq DNA polymerase (Biosystems, New Jersey, USA), 20
mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl2, 200 µM
dNTP (Amersham Bioscience, Bucknghamshire, UK), and
0.7 to 7.0 µL DNA, in a final volume of 50 µL. The PCR
conditions for detection of HPV were: initial denaturation at
95oC for 5 min, followed by 40 cycles of amplification at 95oC
for 1 min, 45oC for 2 min and 72oC for 1.5 min, and a final
extension step at 72oC for 10 min. Typing was done with dot
blot hybridization13. Each dot blot membrane included several
negative and positive controls for HPV types, as well as
PCR products from patients and controls. The membrane
was hybridized overnight as 56oC in 2x standard saline citrate
(SSC), 0.5% sodium dodecylsulfatte (SDS) and 200 µg/mL
DNA with 19 HPV types probes (6,11, 16, 18, 31, 33, 34, 35,
39, 40, 42, 43, 44, 45, 51, 52, 54, 56, 58), most common in
mucosal (genital and oral), and label [32P]dATP. After
hybridization, the unbound probe was of 2x SSC and 0.5%
SDS at room temperature and two 10-min washes of the
same solution at 56o C. The membrane was exposed to x-ray
film at -20o C for 24 h.
For immunohistochemical analysis, the sections were
dewaxed in xylene, rehydrated in decreasing ethanol series,
and rinsed in water. In order to inhibit endogenous
peroxidade activity, the sections were treated by immersion
in 5 changes of 0.3% H2O2 in absolute methanol (5 min each
change) and rinsing in water. Immunohistochemical analysis
was performed using the streptavidin-biotin technique
(streptavidin-biotin complex, SABC; DAKO, Carpinteria,
USA). The reaction was incubated with monoclonal
antibodies: Rb-1 (DAKO) at a dilution 1:50 for 60 min, antigen
retrieval by microwaves, 0.1 M pH 10 Tris-EDTA for 10 min;
WAF1 (DAKO) at a dilution 1:50 for 20 min, antigen retrieval
by steamer, pH 8 EDTA. Careful rinses were performed with
several changes of PBS between each stage of the procedure.
The sections were incubated with diaminobenzidine (Sigma
Chemical CO, St. Louis, MO, USA), then counterstained
lightly with Mayer’s hematoxylin, dehydrated in a graded
ethanol series, allowed to dry in air and mounted with
Permount mounting medium (Fisher Scientific Company,
Pittsburgh, PA, USA).
For counting of labeled cells, representative areas of the
tumor where staining was constant were selected. p21- and
pRb-positive cells were counted under a light microscope
using a counting grid in an area of 0.25 mm2 at a final
magnification of ×1,000 to avoid recounting of the same
histological fields. A total of 1,000 cells for the two markers
were counted in each specimen. Each nucleus was counted
as one unit and the number of positive cells for each case
was obtained by the sum of labeled nuclei. A sample was
considered to be positive for pRb and p21 when at least
10% of the cells were stained.
The results were analyzed statistically by the Student’s
t-test, Mann-Whitney U-test and chi-square test, with the
level of significance set at 95%  (α = 0.05). The research
project was approved by the Research Ethics Committee of
the Federal University of Rio Grande do Norte (Process #
68/03).
RESULTS
Of the 33 samples that were positive for the human  β-
globin gene (Figure 1A), HPV 16 and/or HPV 18 were detected
in 11 (33.33%) (Figure 1B). HPV 18 was identified in 9
(81.81%) cases and HPV 16 and 18 were simultaneously
present in 2 (18.19%) cases.
pRb was expressed in 9/11 (81.82%) HPV-positive tumors
and in 15/22 (68.19%) HPV-negative cases (Figure 2A).
Expression of p21 was observed in 5/11 (45.45%) HPV-
positive tumors and in 7/22 (31.82%) HPV-negative tumors
(Figure 2B). Statistical analysis revealed a significant
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association between the presence of HPV and
immunohistochemical expression of pRb (p=0.044). With
respect to the expression of protein p21, no significant
association was observed between the expression of this
protein and the presence of the virus (p=0.416).
DISCUSSION
This study investigated paraffin-embedded OSCC
specimens for the presence of HPV by PCR. HPV DNA was
detected in 11 (33.33%) of the 33 OSCC cases evaluated.
This percentage is compatible with data reported
elsewhere14-16. However, it is extremely difficult to compare
the results of different reports on HPV in the oral mucosa
because of variations in parameters, such as type of sample
(tissue extracted by biopsy, scraping), preparation method
(fresh, frozen or fixed), ethnic difference between patients,
geographic differences, and sensitivity of the methods used.
Iftner, et al.7 have also reported that differences in DNA
extraction procedures and in transport and storage of the
clinical samples, and especially the use of different DNA
polymerases for PCR, may affect the performance of the
assays.
The most widely used primers are the generic primer
pairs GP5+/GP6+ and MY09/MY11, which are able to amplify
various virus types. In the present study, we used the GP5+/
GP6+ primer pair because, in addition to detecting a variety
of virus types, it amplifies a small fragment (140 bp). This
fact is important when evaluating archived paraffin-
embedded tissue, as done in the present study, which may
show marked DNA fragmentation in some cases.
FIGURE 1- DNA detection by PCR. A: Detection of  b-globin gene DNA. Lanes 1-7, samples from patients; lane 8, C33 cell
DNA without HPV infection; lane 9, negative control (H2O); lane 10, molecular marker (100 bp); B: Detection of HPV DNA in
samples from patients with OSCC. Lanes 1-7, samples from patients; lane 8, HeLa cell DNA infected with HPV 18; lane 9,
negative control (H2O); lane 10, molecular marker (100 pb)
FIGURE 2- Immunohistochemical staining. A: Immunohistochemical staining for pRb in OSCC. Most tumor cells show
intense nuclear staining (SABC, ×200); B: Immunohistochemical staining for p21 in OSCC. The tumor cells show weak
nuclear staining (SABC, ×200).
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In the present study, only HPV 16 and HPV 18 were
detected, which is in agreement with the findings of previous
studies3,5,8,10,20. HPV 18 was present alone in most cases (9/
11, 81.81%) and was detected together with HPV 16 in 2
(18.19%) of the 11 cases. These results agree with those
reported by other investigators who detected HPV 18 in
most of their samples3,20. However, HPV 16 was the most
frequent type in other studies2,5-7.
In view of the complexity of the biological behavior of
malignant tumors, knowledge of the abnormalities that
compromise the cell-cycle regulatory machinery is of
paramount importance. In this respect, the study of
regulatory proteins, such as p21 and pRb, may help
identifying malignant tumors in amore accurate manner. In
the present study, expression of p21 was detected in 5 (45%)
of the 11 HPV-positive tumors and in 7 (31.8%) of the 22
HPV-negative tumors, with no significant difference between
groups. These findings suggest that the presence of HPV is
not sufficient to evaluate the relationship between viral
proteins and cell-cycle regulatory proteins such as p21.
Another important cell-cycle regulatory protein is pRb, which
also shows an important relationship with HPV. Viral
oncoprotein E7 plays a relevant role in tumor progression
by binding to protein pRb, thus releasing transcription factor
E2F which, in turn, activates the transcription of genes that
promote cell-cycle progression and cell proliferation as cited
earlier4. In the present study, a significant difference in the
immunohistochemical expression of pRb was observed
between HPV-positive (9/11, 81.8%) and HPV-negative
tumors (15/22, 68.2%).
Lim, et al.7 examined the alterations of molecules within
the pRb pathway by looking at the presence of homozygous
deletions in p16(INK4A) and the expression patterns of pRb,
cyclin D1 and CDK4, as well as the presence of HPV. pRb
overexpression was found in 20/20 samples, the expression
was mainly observed in all layers of the epithelia, particularly
in the basal layer where cells are actively dividing, and
aberrant pRb expression was found in 12/20 samples.
Strikingly, HPV was present in all samples, suggesting that
it plays a significant role in driving oral carcinogenesis.
Notably, 17/20 of the samples showed more than one
alteration in the pRb pathway. However, Lim, et al.7 did not
find any significant relationship between the presence of
HPV, homozygous deletion of p16(INK4A) and
overexpression of pRb, cyclin D1 and CDK4. Taken together,
these data demonstrate that alterations in the pRb pathway
are a common event and involve the aberration of more than
one molecule within the pathway. Furthermore, the presence
of HPV in all samples suggests that HPV infection may play
an important role in oral carcinogenesis.
Nevertheless, Nemes, et al.9 found no significant
difference in the immunohistochemical expression of pRb
when comparing carcinoma groups with and without HPV.
Yamamoto, et al. 19, evaluating cases of colorectal cancer,
observed that the increase in pRb levels was associated
with the hyperphosphorylated form of the protein (inactive
form). However, Xu, et al.18 stated that antibodies against
pRb label both the phosphorylated and non-phosphorylated
form of the protein.
The present results regarding the immunohistochemical
expression of pRb suggest a higher possibility of HPV
infection in OSCC cases presenting higher pRb expression,
and that binding of HPV protein E7 to pRb is likely to induce
the accumulation of the latter, thus leading to its inactive
form.
CONCLUSIONS
In the present study, HPV DNA was detected in a low
percentage of OSCC cases (33.33%), suggesting that HPV
plays a key role in the development and progression of only
a small subgroup of these carcinomas. HPV 18 was the most
prevalent type, suggesting that this viral type was
specifically related to the development of OSCC in the
studied sample. The immunohistochemical expression of
protein pRb was significantly higher in HPV-positive OSCC
than in HPV-negative tumors, this finding indicating an
important relationship between the virus and pRb in these
tumors. No difference in the immunohistochemical expression
of p21 was observed between HPV-positive and HPV-
negative OSCC cases. It is likely that HPV infection and
immunohistochemical expression of p21 represent
independent factors in these tumors.
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